{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-108436","form_type":"8-K","ticker":"NEUP","cik":"0001191070","company_name":"Neuphoria Therapeutics Inc.","filed_at":"2024-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.868537+00:00","generated_at":"2026-05-29T03:52:19.825760+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Bionomics shareholders approve re-domiciliation to U.S. via Neuphoria; 96% vote in favor","bullets":["96% of votes cast and 87% of shareholders present voted in favor of scheme to re-domicile from Australia to Delaware.","Supreme Court of New South Wales to consider approval at Dec 16 hearing; conditions include expert opinion unchanged.","Implementation expected on or about Dec 24, 2024; Neuphoria shares to trade on Nasdaq under symbol 'NEUP'."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-108436","json":"https://secwatch.observer/filing/0001213900-24-108436.json","markdown":"https://secwatch.observer/filing/0001213900-24-108436.md","text":"https://secwatch.observer/filing/0001213900-24-108436.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1191070/000121390024108436/0001213900-24-108436-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1191070/000121390024108436/ea0224532-8k_bionomics.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T03:52:19.825760+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}